ArticleLeukemia2000

High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission.

A S Stein et al.PubMed ↗Publisher ↗

No numbers read from the abstract.